The PI3K and MAPK/p38 pathways control stress granule assembly in a hierarchical manner by Heberle, Alexander Martin et al.
  
 University of Groningen
The PI3K and MAPK/p38 pathways control stress granule assembly in a hierarchical manner
Heberle, Alexander Martin; Razquin Navas, Patricia; Langelaar-Makkinje, Miriam; Kasack,






IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Heberle, A. M., Razquin Navas, P., Langelaar-Makkinje, M., Kasack, K., Sadik, A., Faessler, E., ...
Thedieck, K. (2019). The PI3K and MAPK/p38 pathways control stress granule assembly in a hierarchical
manner. Life science alliance, 2(2), [201800257]. https://doi.org/10.26508/lsa.201800257
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 13-11-2019
Research Article
The PI3K and MAPK/p38 pathways control stress granule
assembly in a hierarchical manner
Alexander Martin Heberle1,*, Patricia Razquin Navas1,2,*, Miriam Langelaar-Makkinje1, Katharina Kasack3,4,
Ahmed Sadik5,6 , Erik Faessler7 , Udo Hahn7, Philip Marx-Stoelting8, Christiane A Opitz5,9 , Christine Sers3,4 ,
Ines Heiland10 , Sascha Scha¨uble7,11 , Kathrin Thedieck1,2,12
All cells and organisms exhibit stress-coping mechanisms to
ensure survival. Cytoplasmic protein-RNA assemblies termed
stress granules are increasingly recognized to promote cellular
survival under stress. Thus, they might represent tumor vul-
nerabilities that are currently poorly explored. The translation-
inhibitory eIF2α kinases are established as main drivers of
stress granule assembly. Using a systems approach, we identify
the translation enhancers PI3K and MAPK/p38 as pro-stress-
granule-kinases. They act through the metabolic master regu-
lator mammalian target of rapamycin complex 1 (mTORC1) to
promote stress granule assembly. When highly active, PI3K is the
main driver of stress granules; however, the impact of p38
becomes apparent as PI3K activity declines. PI3K and p38 thus
act in a hierarchical manner to drive mTORC1 activity and stress
granule assembly. Of note, this signaling hierarchy is also present
in human breast cancer tissue. Importantly, only the recognition of
the PI3K-p38 hierarchy under stress enabled the discovery of p38’s
role in stress granule formation. In summary, we assign a new pro-
survival function to the keyoncogenic kinases PI3K andp38, as they
hierarchically promote stress granule formation.
DOI 10.26508/lsa.201800257 | Received 27 November 2018 | Revised 6 March
2019 | Accepted 7 March 2019 | Published online 28 March 2019
Introduction
Stress granules are cytoplasmic RNA-protein assemblies, which in a
dynamic, reversible process create a non-membranous compartment
(Kedersha & Anderson, 2007) that recruits mRNAs and signaling
proteins under stress (Kedersha et al, 2013). Thus, stress granules
serve as a stress-driven signaling hub (Kedersha et al, 2013; Heberle
et al, 2015), which buffers translation and promotes survival
(Arimoto et al, 2008; Tsai & Wei, 2010; Thedieck et al, 2013). In recent
years, stress granules have emerged as critical determinants of
cancer cell survival. Stress granule components are often up-
regulated in tumor cells and promote their survival under en-
dogenous and therapeutic stresses (Anderson et al, 2015; Heberle
et al, 2015). Stress granule assembly is initiated by a variety of stress
signals that stall translation (Heberle et al, 2015). The best known
regulators of stress granule assembly are eukaryotic translation
initiation factor 2α (eIF2α) kinases (Anderson et al, 2015), which
inhibit eIF2α to reduce global cap-dependent translation (Holcik,
2015). The subsequent release of monosomal mRNA bound to
noncanonical preinitiation complexes enables the recruitment of
RNA-binding proteins leading to stress granule formation
(Anderson et al, 2015; Panas et al, 2016).
Next to eIF2α kinases, the serine–threonine kinase mechanistic/
mammalian target of rapamycin complex 1 (mTORC1) also has been
suggested to impinge on stress granules, with opposite hypotheses
on the mode of regulation. On the one hand, mTORC1 inhibition has
been proposed to induce stress granules (Hofmann et al, 2012;
Panas et al, 2016). mTORC1 is a master activator of translation
(Saxton & Sabatini, 2017), and therefore translation arrest through
mTORC1 inhibition by small molecule compounds, nutrient dep-
rivation, or stresses has been suggested to promote stress granule
formation. mTORC1 is embedded in a network of oncogenic kinases,
often up-regulated in tumors (Saxton & Sabatini, 2017). Although
triggering tumor metabolism and growth, oncogenic signaling to
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mTORC1 might counteract stress granule assembly, thereby re-
ducing tumor cell survival.
In contrast, other reports suggest that mTORC1 enhances stress
granule assembly through phosphorylation of its substrates ri-
bosomal protein S6 kinase β-1 (p70-S6K) (Sfakianos et al, 2018)
and eukaryotic translation initiation factor 4E-binding protein 1
(4E-BP1) (Fournier et al, 2013). This would suggest that rather than
mTORC1 inhibition, its activation under stress is required to en-
able stress granule formation. If so, stress signals, which activate
mTORC1, could not only enhance tumor cell growth but also sur-
vival. Thus, inhibitors of the kinase network converging on mTORC1,
used as targeted drugs in cancer therapy (Porta et al, 2014; Saxton &
Sabatini, 2017), might disrupt stress granules. Therefore, stress
granules could serve as a novel surrogate marker for therapy
response.
If mTORC1 activity is needed for stress granule assembly, this
implies that mTORC1 is active under stress. Inhibitory stress inputs
to mTORC1 have been reported in much detail (Demetriades et al,
2016; Saxton & Sabatini, 2017; Su & Dai, 2017), but only little is known
about activating stress signals to mTORC1 (Heberle et al, 2015; Su &
Dai, 2017). Furthermore, it is unknown whether such activating
signaling cues inhibit or promote stress granule assembly. To tackle
this gap in our knowledge, we used a combined experimental and
computational modelling approach to systematically identify ki-
nases, which activate mTORC1 upon stress. We identify the onco-
genic kinases phosphoinositide 3-kinase (PI3K) and MAPK p38
(MAPK/p38) as main stress-driven activators of mTORC1. We also
addressed their hierarchy and found that when highly active, PI3K is
the main driver of mTORC1 activity; however, the impact of p38
becomes apparent as PI3K activity declines.
Importantly, we report that both PI3K and p38 promote stress
granule formation. So far, translation-inhibitory cues have been
recognized to mainly drive stress granule assembly (Panas et al,
2016; Protter & Parker, 2016). In contrast, we establish here that the
two major translation activators, PI3K (Robichaud & Sonenberg,
2017; Saxton & Sabatini, 2017) and p38 (Gonskikh & Polacek, 2017;
Robichaud & Sonenberg, 2017), enhance stress granule assembly by
activating mTORC1 under stress. Thus, we assign a new function to
the key oncogenic kinases PI3K and p38: not only do they promote
tumors by enhancing their metabolism and growth but they also
concomitantly enhance stress granule formation, likely increasing
tumor cell survival. We coin the term of pro-stress-granule-kinases
for them and we anticipate that future studies will add further
oncogenic kinases to this family.
Results
mTORC1 activity is required for stress granule formation
The carcinogenic metalloid arsenite is a frequently used tool
compound to study stress granules (Kedersha & Anderson, 2007;
Anderson et al, 2015; Turakhiya et al, 2018). Arsenite induces acute
stress by interference with thiol groups of numerous proteins, such
as, glutathione, glutathione reductase, and thioredoxin reductase,
thus leading to oxidative stress and ultimately translation arrest
(Hughes, 2002; McEwen et al, 2005). In agreement with previous
studies (White et al, 2007; Fournier et al, 2013), we found that in
MCF-7 breast cancer cells, arsenite exposure led to stress-induced
translation arrest, as determined by the phosphorylation of eIF2α at
serine 51 (eIF2α-S51) (Fig 1A and B). Furthermore, arsenite induced
stress granule assembly (Fig 1C), as monitored by the appearance of
cytoplasmic foci, positive for the bona ﬁde stress granule marker
G3BP1 (Ras GTPase-activating protein-binding protein 1). Arsenite
exposure did not affect G3BP1 levels (Fig S1A and B), indicating that
the differences in immunoﬂuorescence were due to granule
localization.
Although inhibitory or activating effects of arsenite on mTOR
have been reported (Chen & Costa, 2018), we found in MCF-7 breast
cancer cells that arsenite stress activated mTORC1, as monitored by
the phosphorylation of p70-S6K at threonine 389 (p70-S6K-T389)
and 4E-BP1 at threonine 37/46 (4E-BP1-pT37/46) (Fig 1A and B). Note
that the 4E-BP1 protein is present in three forms with different
phosphorylation states. The hypophosphorylated α and β forms run
at a lower molecular size than the hyperphosphorylated γ form
(Yamaguchi et al, 2008). All three forms can be phosphorylated by
mTORC1 at T37/46, and thus phosphorylation of all 4E-BP1 forms
has to be considered to assess mTORC1 activity. Stress-induced
phosphorylation of p70-S6K-T389 and 4E-BP1-T37/46 was mediated
by mTORC1, as both events were prevented by the allosteric
mTORC1 inhibitor everolimus (Sedrani et al, 1998; Kirchner et al,
2004), and by the ATP-competitive mTOR inhibitor AZD8055 (Chresta
et al, 2010) (Fig 1D and E).
mTORC1 inhibition (Hofmann et al, 2012; Panas et al, 2016) or
activity (Fournier et al, 2013; Sfakianos et al, 2018) has been sug-
gested to mediate stress granule assembly. We found that both
everolimus and AZD8055 decreased the numbers of G3BP1-positive
foci without affecting G3BP1 levels, suggesting that stress granule
formation was inhibited (Fig 1D, F, and G). Thus, we conclude that
mTORC1 activity is required for stress granule formation.
PI3K promotes stress granule formation
To investigate which pathways promote stress granule assembly
through mTORC1, we ﬁrst monitored the stress-induced phos-
phorylation dynamics across the network upstream of mTOR. For
this purpose, we performed time course experiments upon ar-
senite stress for up to 60 min (Fig S1C and D). Already after 5 min,
arsenite acutely enhanced phosphorylation of the AGC kinase Akt
at T308 (Akt-T308), which remained high throughout the time
course. Class I PI3Ks have been proposed tomediate Akt activation
upon stress (Chen & Costa, 2018). In agreement, stress-induced
Akt-T308 phosphorylation was prevented by the pan-PI3K in-
hibitor wortmannin (Arcaro & Wymann, 1993) and the class I PI3K-
speciﬁc inhibitor GDC-0941 (Folkes et al, 2008) (Fig 2A and B). Upon
insulin, the phosphoinositide-dependent protein kinase PDK1
mediates Akt activation downstream of PI3K, but it is unknown
whether this is also the case under stress. We found that the PDK1
inhibitor GSK2334470 (Najafov et al, 2011) blocked stress-induced
Akt-T308 and reduced p70-S6K-T389 phosphorylation (Fig 2C and
D), demonstrating that PDK1 transduces stress signals to Akt and
mTORC1.
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Figure 1. Stress activates mTORC1 to promote stress granule formation.
(A) Arsenite stress enhances phosphorylation of eIF2α-S51 andmTORC1 substrates. MCF-7 cells were serum-starved and treated with arsenite. p70-S6K-pT389, 4EBP1-pT37/46,
and eIF2α-pS51 were monitored by immunoblot. Data represent six biological replicates. (B) Quantiﬁcation of data shown in (A). eIF2α-pS51, p70-S6K-pT389, and
4E-BP1-pT37/46 levels were compared between control and arsenite-treated cells using a two-tailed t test across six biological replicates. Data represent the mean ± SEM.
**P ≤ 0.01; ***P ≤ 0.001. (C) Arsenite induces stress granules. MCF-7 cells were serum-starved and exposed to arsenite for 30 min. Stress granules were visualized by
immunoﬂuorescence staining of G3BP1. Data represent three biological replicates. Nuclei were visualized usingHoechst 33342. Scale bar: 10μm. (D)mTORmediates inductionof
p70-S6K-pT389 and 4EBP1-pT37/46 by stress. MCF-7 cells were serum-starved and treated with arsenite in the presence of carrier (DMSO), everolimus (100 nM, mTORC1
inhibitor), or AZD8055 (100 nM, mTOR inhibitor). p70-S6K-pT389, 4E-BP1-pT37/46, G3BP1, and eIF2α-pS51 were monitored by immunoblot. Data represent four biological
replicates. (E) Quantiﬁcation of data shown in (D). p70-S6K-pT389 and 4E-BP1-pT37/46 levels were compared between the different treatments using a two-tailed t test across
four biological replicates. Data represent themean ± SEM. ns, not signiﬁcant; *P ≤ 0.05; **P ≤ 0.01. (F)mTOR inhibition reduces stress granule numbers. MCF-7 cells were serum-
starved and treatedwith arsenite for 30min in thepresence of carrier (DMSO), everolimus (100nM,mTORC1 inhibitor), or AZD8055 (100nM,mTOR inhibitor). Stress granuleswere
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In the presence of growth factors and nutrients, Akt inhibits
the heteromeric tuberous sclerosis complex (TSC) (Switon et al,
2016) by phosphorylating its component TSC2 at T1462 (Manning
et al, 2002). Consequently, the TSC complex detaches from ly-
sosomes (Cai et al, 2006; Menon et al, 2014), the platform at which
mTORC1 is active (Saxton & Sabatini, 2017). The TSC is the GTPase-
activating protein for the small GTPase Rheb, which activates
mTORC1 at the lysosome (Manning & Cantley, 2003). Thus, the TSC
acts as an insulin and amino acid–sensitive lysosomal mTORC1
suppressor (Demetriades et al, 2014; Menon et al, 2014). Under
stress, TSC activation and localization to lysosomes has been
proposed as a universal response to cellular stress (Demetriades
et al, 2016). In contrast, we observed enhanced phosphorylation
of TSC2-T1462 upon arsenite stress (Fig S1C and D). Thus, we
report that stress-induced Akt inhibits the TSC. PI3K inhibition
reduced TSC2-T1462 phosphorylation and p70-S6K-pT389 (Fig 2A
and B), demonstrating that under stress, PI3K and Akt signal
through the TSC to activate mTORC1. Thus, we conclude that TSC
inhibition upon stress contributes to mTORC1 activation. We
propose that the TSC acts as an integrator of activating and
inhibitory stress cues, rather than being a universal mediator of
inhibitory stress signals.
We next asked which upstream cue activates PI3K upon stress.
The insulin receptor (IR) has been proposed to enhance PI3K
signaling upon oxidative stress (Mehdi et al, 2005). To test this, we
inhibited the insulin receptor substrate 1 (IRS1) (Fig 2E and F),
required for IR-mediated activation of PI3K (Razquin Navas &
Thedieck, 2017). Whereas IRS1 protein levels were signiﬁcantly
reduced by two siRNAs, Akt-T308 and p70-S6K-T389 phosphory-
lations were not altered (Fig 2E and F). Thus, the IR-IRS1 axis does
not enhance PI3K-PDK1 signaling nor mTORC1 activity upon ar-
senite stress. The super-oncogene RAS is another upstream
regulator of PI3K (Rodriguez-Viciana et al, 1994), known to respond
to growth factor receptors. RAS is a small GTPase, which is active
when GTP-bound. To test whether RAS is activated by arsenite
stress, we analysed GTP loading of RAS. For this purpose, we
performed pull-down experiments with a GST-coupled RAF-
RAS–binding domain (RBD), which speciﬁcally binds active, GTP-
bound RAS but not inactive, GDP-bound RAS. RBD-bound RAS was
detected using a pan-RAS antibody. Arsenite stress enhanced
RAS-GTP levels, as determined by increased RBD-bound RAS (Fig
2G and H), whereas total RAS remained constant (Fig S1E and F).
Thus, arsenite stress enhances RAS activity, which may promote
PI3K signaling to mTORC1.
In summary, we report that stress activation of mTORC1 by PI3K is
mediated by PDK1, Akt, and the TSC. Yet, it is unknown whether PI3K
affects stress granule assembly. Therefore, we analysed stress
granule formation upon arsenite, in the absence or presence of the
PI3K inhibitor wortmannin. PI3K inhibition signiﬁcantly reduced the
number of arsenite-induced stress granules (Fig 2I and J). We,
therefore, conclude that PI3K is required for stress granule
assembly. Thus, we assign a novel function to PI3K as a driver of
stress granule formation, and its pro-stress granule activity might
contribute to PI3K’s oncogenic capacity.
Computational modelling predicts PI3K-independent stress
signals to Akt and mTORC1
Although PI3K and PDK1 inhibitors led to a decline in p70-S6K-pT389,
we observed that also in the presence of these inhibitors p70-S6K-T389
phosphorylation was still signiﬁcantly inducible by arsenite stress (Fig
2B and D). Also stress granule formation was signiﬁcantly reduced, but
still occurred under PI3K inhibition (Fig 2I and J). This suggests that next
to PI3K, there is another stress-induced signaling route, whichpromotes
stress granule assembly.
We went on to identify this cue. In principle, any molecule
downstream or independent of PI3K could be the transducer of the
additional stress signal(s) (Fig S2A). Rather than testing all possible
mediators one by one experimentally, we opted for a systematic
computational approach to guide subsequent experimental in-
vestigation. In the ﬁrst attempt to comprehensively model the
dynamics of the mTOR network upon stress, we built an ordinary
differential equation–based computational model. We designed
our modelling strategy to systematically map stress-responsive
components across the mTOR network.
The initial network structure was based on literature knowledge
on molecules and mechanisms, known to signal to mTOR in re-
sponse to growth factors and nutrients. We then calibrated the
model on dynamic stress-time course data to systematically and
comprehensively identify the stress inputs to the network.
The initial network structure without stress inputs was as follows
(Fig S2A and B, see the Materials and Methods section for details):
amino acids directly activate mTORC1 (Saxton & Sabatini, 2017),
which is deﬁned in our model by the phosphorylation of the
mTORC1 substrates p70-S6K-T389, 4E-BP1-T37/46, and PRAS40-S183
(proline-rich Akt substrate of 40 kD). Downstream of insulin and the
IR, PI3K activates PDK1, which in turn phosphorylates Akt (Akt →
Akt-pT308) (Alessi et al, 1997; Stephens et al, 1998). Akt activates
mTORC1 by inhibiting its endogenous suppressors TSC and PRAS40
through phosphorylation at TSC2-T1462 (Manning et al, 2002) and
PRAS40-T246 (Kovacina et al, 2003; Nascimento et al, 2010), re-
spectively (Akt → TSC2-pT1462; Akt → PRAS40-pT246). Akt and p70-
S6K belong to the family of AGC kinases, which are activated by
phosphorylation in their activation loop and the hydrophobic motif
(Pearce et al, 2010; Leroux et al, 2018). Although the kinase for the
activation loop is PDK1, the kinases phosphorylating the hydro-
phobic motif, historically termed PDK2, differ between AGC kinases
(Pearce et al, 2010; Leroux et al, 2018). The second mTOR complex,
mTORC2, is considered the main PDK2 for Akt. mTORC2 is struc-
turally and functionally distinct from mTORC1 and, in response to
activation by PI3K, phosphorylates Akt at S473 (Manning & Toker,
2017). mTORC1 is the PDK2 for p70-S6K (T389), which is also
visualized by immunoﬂuorescence staining of G3BP1. Nuclei were visualized with Hoechst 33342. Data represent three biological replicates. White squares indicate region
of insert and blue arrows highlight stress granules; scale bar 10 μm. (G)Quantiﬁcation of data shown in (F): number of stress granules (SGs) per cell (normalized to the arsenite
condition) across three biological replicates. Stress granule numbers were compared between the carrier and everolimus, or carrier and AZD8055-treated cells, using a two-
tailed t test across three biological replicates. Data represent the mean ± SEM. *P ≤ 0.05.
PI3K and p38 are pro-stress-granule-kinases Heberle et al. https://doi.org/10.26508/lsa.201800257 vol 2 | no 2 | e201800257 4 of 22
PI3K and p38 are pro-stress-granule-kinases Heberle et al. https://doi.org/10.26508/lsa.201800257 vol 2 | no 2 | e201800257 5 of 22
phosphorylated by PDK1 at T229 (Pullen et al, 1998). The two AGC
kinase modules in our model include all possible combinations
of phosphorylation states, that is, non-phosphorylated, single-,
or double-phosphorylated species. All single- and double-
phosphorylated Akt species are deﬁned as active in our model,
whereby phosphorylation at the PDK1 and 2 sites have additive
effects on Akt activity. For p70-S6K in our model, only the species
phosphorylated at T389 is deﬁned as active, as p70-S6K activity
toward its substrate IRS1-S636/639 has been reported to be
mTORC1 dependent (Carlson et al, 2004; Um et al, 2004; Tzatsos &
Kandror, 2006).
We calibrated our dynamic model with quantitative time course
data recorded for up to 60 min upon arsenite exposure (Fig S1C and
D). As we had found that the PI3K-Akt signaling axis transduces a
stress signal, which enhances mTORC1 activity and stress granule
formation (Fig 2A–D, I, and J), we also recorded perturbation time
course datasets, in which we inhibited PI3K (wortmannin) or Akt
(MK-2206 [Hirai et al, 2010]) (Fig S3). To include the inhibitors into
our model, we calculated the extent of inhibition for wortmannin or
MK-2206 by quantifying the relative decrease of Akt-T308 or
TSC2-T1462 phosphorylation, respectively, as these are readouts for
PI3K and Akt activity (Fig S2C–E). The extent of inhibition was de-
termined as being 100% for wortmannin (modelled as full in-
hibition) and 83% for MK-2206 (modelled as partial inhibition).
When calibrated on stress time course data, the model with
nutritional inputs only (model I, Supplemental Data 1) was not able
to ﬁt the measured data for most readouts, including p70-S6K-T389,
Akt-T308, TSC2-T1462, p70-S6K-T229, and IRS1-S636/639 phos-
phorylation (experimental data shown as dots and simulations
shown as lines in Fig S4). This formally showed that a model without
stress-speciﬁc inputs is not sufﬁcient to reproduce the stress re-
sponse of the network.
Thus, one or several additional inputs were needed for the model
to be able to ﬁt the stress time course data. For this purpose, we
added, in agreement with our previous ﬁndings (Fig 2), a stress input
at the level of PI3K (model II, shown in Figs 3A and S5 and
Supplemental Data 2), and calibrated this model on our time course
data (Figs S1C, D, and S3). Model II was able to simulate the dynamic
response of all components across the mTOR network to arsenite
stress (Fig 3B, blue; Fig S6A and B). Hence, the addition of a stress
input to PI3K improved the ﬁt between the simulations and the data.
However, for PI3K perturbation (wortmannin), the model failed to
simulate the remaining activity at the level of p70-S6K-pT389 and Akt-
pS473 as well as other readouts across the network (Fig 3B, orange;
Fig S6C). This conﬁrmed that stress activation of PI3K is not sufﬁcient
to explain the dynamic stress response of the mTOR network. Thus,
we concluded that additional stress inputsmight further improve the
ﬁt between the simulated and the measured perturbation data.
To identify further stress-responsive components in the mTOR
network, we generated a series of models, in which we systemat-
ically included a second stress input to every species across our
model II. We compared the ﬁt between the model simulations and
the measured data by calculating the Akaike information criterion
(AIC) (Table 1). We considered that a model represented an im-
provement over the previous version if the AIC was reduced by at
least 5%. Only two models reached the threshold (Table 1, models 1
and 2), in both of which the second stress input targeted the
phosphorylation of Akt at serine 473 (Akt → Akt-pS473 and Akt-
pT308 → Akt-pT308-pS473). From these two models, we chose to
proceed with model 1 (now renamed model III) as it had the lowest
AIC value (1,127) (Figs 3C and S7 and Supplemental Data 3). Model III,
with two stress inputs on PI3K and Akt-pS473, correctly simulated
the remaining activity at the level of Akt-pS473 and p70-S6K-pT389
under PI3K inhibition (Fig 3D, orange; Fig S8).
In our models I–III, the full Akt module including phosphory-
lation at T308 and S473 was upstream of mTORC1. Hence, we hy-
pothesized that the improved ﬁt between the p70-S6K-pT389
simulation and measured data in model III might come from the
connection between Akt-pS473 and mTORC1. To test whether this
was the case, we removed the link between Akt-pS473 and mTORC1
from our model (model IV, Figs S9 and S10 and Supplemental Data
4). Indeed, this model IV failed to simulate the remaining activity of
Figure 2. PI3K enhances stress granule formation through mTORC1 activation.
(A)mTORC1 is activated by arsenite in a PI3K-dependent manner. MCF-7 cells were serum-starved and treated with arsenite in the presence of carrier (DMSO), wortmannin
(100 nM, PI3K inhibitor), or GDC-0941 (1 μM, PI3K inhibitor). Akt-pT308, TSC2-pT1462, p70-S6K-pT389, and eIF2α-pS51 were monitored by immunoblot. Data represent
three biological replicates. (B) Quantiﬁcation of data shown in (A). Akt-pT308, TSC2-pT1462, and p70-S6K-pT389 levels were compared between carrier and wortmannin as
well as carrier and GDC-0941-treated cells using a two-tailed t test across three biological replicates. Data represent the mean ± SEM. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001.
(C) PDK1 mediates stress activation of mTORC1. MCF-7 cells were serum-starved and treated with arsenite in the presence of carrier (DMSO) or GSK2334470 (1 μM,
PDK1 inhibitor). Akt-pT308, p70-S6K-pT389, and eIF2α-pS51 were monitored by immunoblot. Data represent three biological replicates. (D) Quantiﬁcation of data shown in
(C). Akt-pT308 and p70-S6K-pT389 levels were compared between carrier and GSK2334470-treated cells using a two-way ANOVA followed by a Bonferroni
multiple comparison test across three biological replicates. Data represent the mean ± SEM. P-values for the Bonferroni multiple comparison tests are shown above the
columns. *P ≤ 0.05; ***P ≤ 0.001. (E) Stress activation of mTORC1 is IRS1 independent. MCF-7 cells treated with non-targeting scramble siRNA (siControl) or with two different
siRNA sequences targeting IRS1 (siIRS1 #1 and #2) were serum-starved and treated with arsenite. Akt-pT308, p70-S6K-pT389, and eIF2α-pS51 were monitored by
immunoblot. Data represent four biological replicates. (F)Quantiﬁcation of data shown in (E). IRS1, Akt-pT308, and p70-S6K-pT389 levels were compared between siControl,
siIRS1 #1–, and siIRS2 #2–treated cells using a two-way ANOVA followed by a Bonferroni multiple comparison test across four biological replicates. Data represent themean
± SEM. P-values for the Bonferroni multiple comparison tests are depicted above the corresponding time point. ns, not signiﬁcant; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001. (G)
Stress activates RAS. MCF-7 cells were serum-starved and treated with arsenite. RAS activity was measured using GST-coupled RAF-RAS–binding domain pull down
experiments. Data represent three biological replicates. (H) Quantiﬁcation of data shown in (G). RAS-GTP levels were compared over an arsenite time course using a one-
way ANOVA followed by a Bonferroni multiple comparison test across three biological replicates. Data represent the mean ± SEM. The signiﬁcances for the Bonferroni
multiple comparison tests between time points is shown above the column, the P-value for the ANOVA is P = 0.0318. *P ≤ 0.05. (I) PI3K inhibition reduces stress
granule numbers. MCF-7 cells were serum-starved and treated with arsenite for 30 min in the presence of carrier (DMSO) or wortmannin (100 nM, PI3K inhibitor).
Stress granules were visualized by immunoﬂuorescence staining of G3BP1. Nuclei were visualized with Hoechst 33342. Data represent four biological replicates. White
square indicates region of insert and blue arrow highlights stress granules; scale bar 10 μm. (J) Quantiﬁcation of data shown in (I): number of stress granules
(SGs) per cell (normalized to the arsenite condition) across four biological replicates. A two-tailed t test across four biological replicates was applied. Data represent the
mean ± SEM. **P ≤ 0.01; ***P ≤ 0.001.
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p70-S6K-pT389 under PI3K perturbation (Fig S10C). Thus, the ﬁt
between the p70-S6K-pT389 simulations and measured data in
model III is mediated by Akt-pS473. In agreement, it has been
proposed that Akt-S473 phosphorylation can enhance mTORC1
activity (Hart & Vogt, 2011). Yet, in contrast, several studies have
claimed that there is no positive link between mTORC1 andmTORC2
(Guertin et al, 2006; Jacinto et al, 2006), the main mediator of Akt-
S473 phosphorylation.
Figure 3. Computational model predicts three stress inputs on PI3K, Akt, and mTORC1.
(A) Scheme of model II, with only one stress input on PI3K (Fig S5). The corresponding AIC value is indicated at the top. (B) Simulated response of Akt-pT308, Akt-
pS473, and p70-S6K-pT389 to arsenite stress in a system without (blue) or with (orange) wortmannin (PI3K perturbation) using model II, with one stress input on PI3K. Blue
dots represent experimental data from arsenite time course (Fig S1C and D) and orange dots represent experimental data from arsenite time course + PI3K
perturbation (Fig S3A and B). Lines represent computational simulation. Data represent the mean ± SEM. Simulations of all used observables are shown in Fig S6.
(C) Scheme of model III, with two stress inputs on PI3K and Akt-pS473 (Fig S7). The corresponding AIC value is indicated at the top. (D) Simulated response of
Akt-pT308, Akt-pS473, and p70-S6K-pT389 to arsenite stress in a system without (blue) or with (orange) wortmannin (PI3K perturbation) using model III, with two stress
inputs on PI3K and Akt-pS473. Dots represent experimental data and lines represent computational simulation as described in (B). Data represent the mean ± SEM.
Simulations of all used observables are shown in Fig S8. (E) Scheme of model V, with three stress inputs on PI3K, Akt-pS473, and mTORC1 (Fig S11). The corresponding
AIC value is indicated at the top. (F) Simulated response of Akt-pT308, Akt-pS473, and p70-S6K-pT389 to arsenite stress in a system without (blue) or with (orange)
wortmannin (PI3K perturbation) using model V, with three stress inputs on PI3K, Akt-pS473, and mTORC1. Dots represent experimental data and lines represent
computational simulation as described in (B). Data represent the mean ± SEM. Simulations of all used observables are shown in Fig S12.
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Table 1. AIC values for input search.
Model no. Substrate Product AIC AICc BIC
Single stress input
II PI3K PI3K_p 8,788 8,844 9,126
Second stress input in addition to PI3K
1 Akt Akt_pS473 1,127 1,185 1,469
2 Akt_pT308 Akt_pT308_pS473 1,535 1,593 1,877
3 PDK1_cyt PDK1_mem 8,595 8,653 8,937
4 Akt Akt_pT308 8,597 8,655 8,939
5 TSC2 TSC2_pT1462 8,599 8,657 8,941
6 PRAS40 PRAS40_pT246 8,623 8,681 8,965
7 PRAS40 PRAS40_pS183 8,663 8,721 9,005
8 p70_S6K p70_S6K_pT389 8,667 8,724 9,009
9 PRAS40_pS183 PRAS40_pT246_pS183 8,704 8,761 9,045
10 p70_S6K p70_S6K_pT229 8,706 8,763 9,048
11 IR_beta IR_beta_pY1146 8,733 8,791 9,075
12 IRS1 IRS1_loc_pS636 8,734 8,791 9,076
13 IRS1 IRS1_loc 8,738 8,795 9,080
14 4EBP1 4EBP1_pT37_46 8,762 8,820 9,104
15 PRAS40_pS183 PRAS40 8,763 8,821 9,105
16 p70_S6K_pT229 p70_S6K_pT229_pT389 8,768 8,826 9,110
17 p70_S6K_pT389 p70_S6K_pT229_pT389 8,776 8,834 9,118
18 Akt_pT308_pS473 Akt_pT308 8,777 8,835 9,119
19 Akt_pT308_pS473 Akt_pS473 8,781 8,839 9,123
20 PRAS40_pT246 PRAS40_pT246_pS183 8,781 8,839 9,123
21 IRS1_loc IRS1_loc_pS636 8,781 8,839 9,123
22 TSC2_pT1462 TSC2 8,781 8,839 9,123
23 PI3K_p PI3K 8,781 8,839 9,123
24 PDK1_mem PDK1_cyt 8,781 8,839 9,123
25 p70_S6K_pT229 p70_S6K 8,781 8,839 9,123
26 IR_beta_pY1146 IR_beta 8,782 8,840 9,124
27 Akt_pS473 Akt_pT308_pS473 8,783 8,841 9,125
28 PRAS40_pT246 PRAS40 8,788 8,846 9,130
29 PRAS40_pT246_pS183 PRAS40_pS183 8,788 8,846 9,130
30 4EBP1_pT37_46 4EBP1 8,790 8,848 9,132
31 PRAS40_pT246_pS183 PRAS40_pT246 8,790 8,848 9,132
32 p70_S6K_pT229_pT389 p70_S6K_pT389 8,791 8,849 9,133
33 Akt_pS473 Akt 8,791 8,849 9,133
34 Akt_pT308 Akt 8,797 8,855 9,139
35 IRS1_loc_pS636 IRS1 8,799 8,857 9,141
36 p70_S6K_pT389 p70_S6K 8,799 8,857 9,141
37 p70_S6K_pT229_pT389 p70_S6K_pT229 8,803 8,861 9,145
Model ﬁtting quality determined by computing the AIC, the AIC corrected for small sample sizes (AICc), or the BIC. Upper part: ﬁtting quality of model II. Lower
part: ﬁtting quality of model II with an additional stress input. Each value is computed by running Latin hypercube sampling 500 times with the indicated stress
inputs.
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Therefore, it is unknown whether under stress, Akt-pS473 is
upstream of mTORC1. Thus, we postulated two hypotheses: when
PI3K is inhibited, (1) stress-induction of Akt-pS473mediatesmTORC1
activation (Fig 3C) and in this case, model III is correct; or (2) Akt-
S473 phosphorylation does not activate mTORC1 and there is an
additional stress input to mTORC1 (Fig 3E). If hypothesis (2) is
correct, the addition of this third input to our model would be
expected to further improve the ﬁt between the model simulations
and the measured data. To test the two hypotheses in silico, we
added a third stress input tomTORC1 intomodel IV (model V, Figs 3E
and S11 and Supplemental Data 5). Model V with stress inputs on
PI3K, Akt-pS473, and mTORC1 provided a good ﬁt between simu-
lations and experimental dynamic data for all readouts (Figs 3F and
S12). The comparison of the simulations (Fig S12) to our initial model
II (Fig S6) with the single stress input on PI3K showed an improved
ﬁt for all readouts upon stress and perturbations with wortmannin
or MK-2206. In favour of hypothesis (2), model V indeed yielded a
lower AIC value (Fig 3E, AIC 1,109) than model III with two stress
inputs only (Fig 3C, AIC 1,127). However, as the decrease in AIC was
below the threshold of 5%, we decided also to test both hypotheses
experimentally.
mTORC1 activation by stress is independent of Akt and mTORC2,
when PI3K is inactive
We ﬁrst tested the hypothesis that in the absence of PI3K activity,
stress-induced Akt-pS473 activates mTORC1 (hypothesis 1, Fig 3C).
For this purpose, we inhibited Akt-S473 phosphorylation by Akt1 and
Akt2 double knockdown (siAkt1/2) to target the major Akt isoforms
expressed in MCF-7 cells (Jordan et al, 2004; Le Page et al, 2006). We
analysed mTORC1 activation upon arsenite stress by detecting
p70-S6K-pT389 when PI3K was active or inhibited by wortmannin.
siAkt1/2 expectedly reduced Akt1 and Akt2 protein levels as well as
phosphorylation on T308 and S473 (Figs 4A–C, S13A, and B). When
PI3K was active, siAkt1/2 reduced p70-S6K-T389 phosphorylation,
indicating that AktmediatesmTORC1 activation by stress (Fig 4A and
B). In contrast, when PI3K was inactivated by wortmannin, siAkt1/2
did not further reduce p70-S6K-T389 phosphorylation, although it
was still inducible by arsenite stress (Fig 4A and C). This indicated
that in the absence of PI3K activity, mTORC1 activation by stress was
independent of Akt. Thus, stress-induction of Akt-pS473 does not
mediate mTORC1 activation, when PI3K is inactive. We, therefore,
rejected hypothesis (1).
To further test this, we inhibited the kinase, which phosphory-
lates Akt-S473. mTORC2 is widely recognized as the main kinase
targeting Akt-S473 (Sarbassov et al, 2005; Jacinto et al, 2006;
Manning & Toker, 2017). To disassemble and inhibit mTORC2, we
inhibited the speciﬁc mTORC2 component rapamycin-insensitive
companion of mTOR (rictor) (Sarbassov et al, 2004; Jacinto et al,
2006). Rictor knockdown signiﬁcantly reduced rictor levels (Fig S13C
and D) but did not inhibit p70-S6K-pT389 (Fig 4D–F). This indicates
that the stress signal tomTORC1 is not transduced throughmTORC2,
again supporting the rejection of hypothesis (1).
As expected, rictor knockdown reduced Akt-S473 phosphoryla-
tion in PI3K-proﬁcient cells (Fig 4D and E). To our surprise, we found
that upon PI3K inhibition, rictor knockdown did not affect Akt-pS473
even though it was induced by arsenite stress (Fig 4D and F). This
indicates that in the absence of PI3K activity, mTORC2 does not
mediate Akt-S473 phosphorylation. We further conﬁrmed this
ﬁnding with Torin1 (Thoreen et al, 2009), an ATP-analogue inhibitor,
which targets mTOR in both complexes. Torin1 abolished p70-S6K-
T389 phosphorylation (Fig S13E), indicative of mTORC1 inhibition.
Akt-S473 phosphorylation was reduced by Torin1 (Fig S13F) to the
same level as with wortmannin (Fig S13E), indicating that PI3K and
mTORC2 act in the same axis to enhance Akt-pS473. Yet, when PI3K
was inactive, Torin1 could not further reduce Akt-pS473, although it
remained inducible by arsenite stress (Fig S13G), again suggesting
that stress-induction of Akt-pS473 is notmediated bymTORC2 when
PI3K is inactive. Which stress-inducible kinase targets Akt-S473
when PI3K is inactive?
p38/MAPK signaling mediates separate stress inputs to Akt and
mTORC1
Next to mTORC2 (Manning & Toker, 2017), at least seven other
candidates have been proposed as PDK2s for Akt over the last two
decades (DNAPK, ILK, LRRK2, MK2, PKCA, PKCB, and TBK1; Figs 4G and
S13H, see S13H for citations). MEDLINE and PubMed Central (PMC)
contain >28 million abstracts and >1.7 million full texts, of which
more than 50,000 reference the aforementioned seven kinases
and/or Akt (Fig 4G). To comprehensively evaluate this literature in
an unbiased manner for a kinase that is likely to phosphorylate Akt
under stress, we adopted an automated, heuristic strategy. We
developed a text mining pipeline, which enabled us to quantita-
tively evaluate the full text corpus of MEDLINE and PMC, based on
numbers of hits. Furthermore, we opted for a linguistic approach
that evaluated logical connections between two terms, rather than
just counting their co-occurrence.
The text mining pipeline included automated recognition and
annotation of genes and proteins in all MEDLINE abstracts and the
open access subset of PMC full texts (Fig 4G). Afterwards, we
identiﬁed sentences from the complete text corpus that fulﬁlled
the following conditions: (i) referenced Akt1, Akt2, Akt3 or any known
PDK2 for Akt, (ii) referenced any other gene or protein name and (iii)
included a functional relation term like “phosphorylation” or
“regulation” that linguistically linked occurrences from (i) and (ii). In
total, we obtained 52,413 sentences stating a functional relationship
of a protein/gene with Akt or any PDK2. This list was further ﬁltered
for the string “stress,” to restrict our dataset to stress-related
regulatory events (Supplemental Data 6). Based on the number
of publications and sentences, in which the hits occurred, we
generated a list of targets. The top hit was the MAPK p38 (Fig 4H),
which has been proposed to activate the PDK2 candidate MAPKAPK2
under stress (MK2 and MAPK-activated protein kinase 2) (Rouse
et al, 1994).
As we aimed to identify the kinase, which in a PI3K-independent
manner controls Akt-pS473 under arsenite stress, we next tested
whether MK2 is required for Akt-S473 phosphorylation when PI3K is
inactive. For this purpose, we used the small compound inhibitor
PF3644022 (Mourey et al, 2010) to inhibit MK2 in arsenite-stressed
cells (Fig 4I–K). When PI3K was active, PF3644022 did not affect Akt-
pS473 (Fig 4I and J). In contrast, when PI3K was inhibited, PF3644022
signiﬁcantly reduced Akt-S473 phosphorylation, indicating that
during stress, MK2 phosphorylates Akt-S473 in a PI3K-independent
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manner (Fig 4I and K). To further conﬁrm our ﬁndings, we repeated
the same experiment with MK2 siRNA–mediated knockdown, with
similar results (Fig S13I–K). We also used a small compound in-
hibitor of p38 (LY2228820 [Tate et al, 2013; Campbell et al, 2014]),
which efﬁciently inhibited p38 and MK2 as monitored by MK2-T334
phosphorylation (Ben-Levy et al, 1995) (Fig 5A). p38 inhibition also
signiﬁcantly reduced Akt-pS473 (Fig 5A–C), and this effect was more
pronounced when PI3K was inhibited. Thus, we conclude that MK2,
downstream of p38, is the stress-induced PDK2, which phosphor-
ylates Akt independently of PI3K.
MK2 inhibition did not reduce p70-S6K-pT389 phosphorylation
(Figs 4I–K and S13I–K), suggesting that MK2 does not activate
mTORC1 under stress. This is in agreement with our ﬁnding that Akt
does not regulate mTORC1 when PI3K is inactive (Fig 4A and C) and
again highlights that stress activation of Akt and mTORC1 are two
separate molecular events. In contrast, p38 inhibition did reverse
stress-induced p70-S6K-T389 phosphorylation when PI3K was in-
active (Fig 5A and C). Thus, we conclude that independently of MK2,
p38 mediates stress activation of mTORC1.
Taken together, our ﬁndings support hypothesis (2) (Fig 3E,
model V), in which three separate stress inputs signal to the mTOR
network: (i) PI3K signals through PDK1, Akt-pT308, and the TSC to
mTORC1 and through mTORC2 to Akt-pS473; (ii) the p38-MK2 axis
signals to Akt-S473; and (iii) mTORC1 is activated by p38 in an MK2-
independent manner. Of note, p38 signaling to Akt and mTORC1 is
PI3K independent.
p38 and PI3K promote stress granule formation in a hierarchical
manner
Our ﬁndings suggest a hierarchy of stress inputs to mTORC1: when
highly active, PI3K dominates stress signaling through Akt and the
TSC to mTORC1. As PI3K activity declines, p38 takes over to activate
mTORC1. This hierarchy can be observed for both bona ﬁde mTORC1
readouts, p70-S6K-pT389 (Fig 5A–C) and 4EBP1-pT37/46 (Figs 5D and
S14A). This hierarchy was also recapitulated by our computational
model V, whose simulations showed a much stronger contribution
of p38 to mTORC1 activation by stress when PI3K was inactive, as
compared with active PI3K (Fig 5E).
To deﬁne the threshold of PI3K activity, at which the contribution
of p38 to mTORC1 activation by stress becomes apparent, we
performed a dose-response experiment. To analyse the effect of
p38 inhibition on stress-induced p70-S6K-pT389 at different levels
of PI3K activity, we combined the p38 inhibitor LY2228820 with
wortmannin concentrations from 10 to 100 nM (Figs 5F and S13L).
The effect of p38 inhibition on p70-S6K-pT389 became signiﬁcant
when PI3K activity (calculated based on Akt-pT308) was 40% or
lower. Based on this result, the threshold of PI3K activity for p38 to
signiﬁcantly contribute to mTORC1 activation by stress can be
estimated to be 40% in MCF-7 cells.
How does p38 activate mTORC1? So far, two mechanisms have
been proposed: (i) p38 has been suggested to activate mTORC1
through MK2 (Li et al, 2003; Cully et al, 2010). Yet, in our hands, MK2
inhibition did not affect mTORC1 activity (Figs 4I–K and S13I–K), in-
dicating thatmTORC1 activation by p38 was MK2 independent; (ii) p38
has been proposed to directly phosphorylate raptor and activate
mTORC1 (Wu et al, 2011), but it is unknown whether this occurs in a
PI3K-dependent manner. Hence, in cells with low PI3K activity, p38
might activate mTORC1 either through raptor or via a hitherto un-
knownmechanism, which requires further investigation in the future.
To test if the hierarchy between PI3K and p38 is a general feature
of stress signaling to mTORC1, we investigated this mechanism in
four further cell lines, out of which three were of tumor origin (HeLa,
cervix carcinoma; CAL51, breast cancer; and LN18, glioblastoma),
whereas one was a non-malignant cell line (HEK293T, human
embryonic kidney). Surprisingly, we found that all four cell lines
exhibited very low p70-S6K levels, as compared with MCF-7, whereas
4E-BP1 levels were similar or higher than in MCF-7 (Fig S14B and C).
Thus, we opted for 4E-BP1-T37/46 as the readout to compare the
mTORC1 response to p38 inhibition across the ﬁve different cell
Figure 4. Stress promotes Akt-S473 phosphorylation via the p38-MK2 axis when PI3K is inactive.
(A) mTORC1 stress activation is not mediated via Akt when PI3K is inactive. MCF-7 cells were serum-starved and treated with arsenite in the presence of carrier
(DMSO) or wortmannin (100 nM, PI3K inhibitor) in cells treated with non-targeting scramble siRNA (siControl) or with siRNA-pools targeting Akt1 and Akt2. Akt1, Akt2,
Akt-pT308, Akt-pS473, p70-S6K-pT389, and eIF2α-pS51 were monitored by immunoblot. Data represent six biological replicates. (B) Quantiﬁcation of data shown in
(A) when PI3K is active. Akt-pS473 and p70-S6K-pT389 levels were compared between siControl and siAkt1/2-treated cells using a two-way ANOVA followed by a
Bonferroni multiple comparison test across six biological replicates. Data represent the mean ± SEM. P-values for the Bonferroni multiple comparison tests are shown
above the columns. *P ≤ 0.05; ***P ≤ 0.001. (C) Quantiﬁcation of data shown in (A) when PI3K is inactive. Akt-pS473 and p70-S6K-pT389 levels were compared
between siControl and siAkt1/2-treated cells in the presence of wortmannin using a two-way ANOVA followed by a Bonferroni multiple comparison test across six
biological replicates. Data represent the mean ± SEM. P-values for the Bonferroni multiple comparison tests are shown above the columns. ns, not signiﬁcant; ***P ≤ 0.001.
(D) Akt-pS473 is not mediated by mTORC2 when PI3K is inactive. MCF-7 cells were serum-starved and treated with arsenite in the presence of carrier (DMSO) or wortmannin
(100 nM, PI3K inhibitor) in siControl versus siRictor-treated cells. Rictor, Akt-pT308, Akt-pS473 p70-S6K-pT389, and eIF2α-pS51 were monitored by immunoblot. Data
represent ﬁve biological replicates. (E) Quantiﬁcation of data shown in (D) when PI3K is active. Akt-pS473 and p70-S6K-pT389 were compared between siControl and
siRictor using a two-way ANOVA followed by a Bonferroni multiple comparison test across ﬁve biological replicates. Data represent the mean ± SEM. The P-values for the
Bonferroni multiple comparison tests are shown. **P ≤ 0.01. (F) Quantiﬁcation of data shown in (D) when PI3K is inactive. Akt-pS473 and p70-S6K-pT389 were compared
between siControl and siRictor-treated cells in the presence of wortmannin using a two-way ANOVA followed by a Bonferroni multiple comparison test across ﬁve
biological replicates. Data represent themean ± SEM. The P-values for the Bonferroni multiple comparison tests are shown. *P ≤ 0.05. (G)Workﬂow of text mining approach.
(H) List of top 10 identiﬁed interaction partners using the text mining approach, including an example sentence (Borodkina et al, 2014). (I) MK2 phosphorylates
Akt-S473 when PI3K is inactive. MCF-7 cells were serum-starved and treated with arsenite in the presence of carrier (DMSO) or wortmannin (100 nM, PI3K inhibitor). In
addition, the cells were treated with carrier (DMSO) or PF3644022 (1 μM, MK2 inhibitor). Akt-pT308, Akt-pS473, p70-S6K-pT389, and eIF2α-pS51 were monitored by
immunoblot. Data represent four biological replicates. (J) Quantiﬁcation of data shown in (I) when PI3K is active. Akt-pS473 and p70-S6K-pT389 levels were compared
between carrier (DMSO) and PF3644022-treated cells using a two-way ANOVA followed by a Bonferroni multiple comparison test across four biological replicates.
Data represent the mean ± SEM. The P-values for the Bonferroni multiple comparison tests are shown. (K) Quantiﬁcation of data shown in (I) when PI3K is
inactive. Akt-pS473 and p70-S6K-pT389 levels were compared between wortmannin- and wortmannin + PF3644022–treated cells using a two-way ANOVA followed by a
Bonferroni multiple comparison test across four biological replicates. Data represent the mean ± SEM. The P-values for the Bonferroni multiple comparison tests are
shown. **P ≤ 0.01. ns, not signiﬁcant.
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lines (Figs 5G and S14D–G). In cells which exhibited enhanced PI3K
activity upon stress (enhanced Akt-pT308 in MCF-7, CAL51, LN18, and
HEK293T cells), PI3K inhibition was required to observe an effect of
p38 inhibition on 4E-BP1-T37/46 phosphorylation (Figs 5D, G, S14A,
and D–F). In HeLa cells, PI3K was not responsive to stress, and here
p38 inhibition reduced 4E-BP1-pT37/46 also without additional
PI3K inhibition (Figs 5G and S14G). Thus, p38 inhibition directly
affects mTORC1 in cells with low PI3K activity; however, in cells
with high PI3K, the impact of p38 only becomes observable when
PI3K is suppressed. Hence, we conclude that the hierarchy be-
tween PI3K- and p38-mediated stress activation of mTORC1 is a
general mechanism preserved among different cancer-derived
and nonmalignant cell types.
The hierarchy of PI3K and p38 in inducing mTORC1 under stress
suggests that the same hierarchy might also exist at the level of
stress granule assembly. If so, the effect of p38 inhibition on stress
granules would only be observable when PI3K activity is low. To test
this, we treated arsenite-stressed cells with the p38 inhibitor
LY2228820 without or with PI3K inhibition (wortmannin) and ana-
lysed the number of stress granules per cell (Fig 5H and I). Although
the p38 inhibitor did not affect stress granule numbers when PI3K
was active, p38 inhibition did reduce the amount of stress granules
in cells with inactive PI3K. Thus, we identify p38 as a novel regulator
of stress granules.
We conclude that the two pro-stress-granule-kinases PI3K and
p38 drive stress granule assembly in a hierarchical manner, as the
importance of p38 for stress granule formation becomes apparent
as PI3K activity declines.
Discussion
The present work is the ﬁrst attempt to model the full mTOR
network, including both mTOR complexes, to identify activating
stress inputs and their co-dependency. Furthermore, we generated
and applied an automated, heuristic text mining pipeline, which
allowed us to quantitatively evaluate the full text corpus of
MEDLINE and PMC to comprehensively evaluate connections be-
tween signaling components under stress. Based on model-guided
experimentation, we established that PI3K and p38 activatemTORC1
in a hierarchical manner (Fig 6A). Only the understanding of this
hierarchy at the level of signaling enabled the discovery of p38 as a
pro-stress-granule-kinase.
Although inhibitory or activating roles of mTORC1 in stress
granule assembly have been postulated (Fournier et al, 2013;
Hofmann et al, 2012; Panas et al, 2016; Sfakianos et al, 2018), we
ﬁnd here that mTORC1 acts as a pro-stress-granule-kinase. How
does this function relate to earlier ﬁndings that stress granules
inhibit mTORC1 (Thedieck et al, 2013; Wippich et al, 2013)? Although
stress signaling through PI3K and p38 to mTORC1 enhances stress
granule formation, stress granules in turn inhibit mTORC1 activity,
thereby likely restricting their own assembly. This dual mechanism
implies a negative feedback loop that might contribute to the tight
balance of stress granule formation and clearance, to allow cell
survival under stress.
Stress granules are induced by a variety of stresses, including
heavy metals, oxidative, ER (endoplasmic reticulum), nutritional,
heat, and osmotic stress; UV and γ irradiation; and chemothera-
peutic agents (Anderson et al, 2015). Do PI3K and p38 respond
to similar stresses? Indeed, PI3K is activated by heavy metals
(Carpenter and Jiang, 2013), γ irradiation (Datta et al, 2014), heat
(Thompson et al, 2016), and oxidative stress (Kosmidou et al, 2001).
Also, p38 responds to many stressors known to enhance stress
granules, including ER stress, oxidative stress, nutritional stress,
and DNA damage (Bonney, 2017). Thus, PI3K and p38 may be uni-
versal pro-stress-granule-kinases.
So far, mechanisms which suppress translation under stress have
been perceived as the main triggers of stress granule assembly. Most
Figure 5. p38 promotes mTORC1 activation and stress granule formation when PI3K is inactive.
(A) p38 mediates mTORC1 activation when PI3K is inactive. MCF-7 cells were serum-starved and treated with arsenite in the presence of carrier (DMSO) or
wortmannin (100 nM, PI3K inhibitor). In addition, the cells were treated with carrier (DMSO) versus LY2228820 (1 μM, p38 inhibitor). MK2-pT334, Akt-pT308, Akt-
pS473, p70-S6K-pT389, and eIF2α-pS51 were monitored by immunoblot. Data represent ﬁve biological replicates. (B)Quantiﬁcation of data shown in (A) when PI3K is active.
Akt-pS473 and p70-S6K-pT389 were compared between carrier (DMSO) and LY2228820-treated cells using a two-way ANOVA followed by a Bonferroni
multiple comparison test across ﬁve biological replicates. Data represent the mean ± SEM. The P-values for the Bonferroni multiple comparison tests are shown. ***P ≤
0.001. (C) Quantiﬁcation of data shown in (A) when PI3K is inactive. Akt-pS473 and p70-S6K-pT389 were compared between wortmannin- and wortmannin +
LY2228820–treated cells using a two-way ANOVA followed by a Bonferroni multiple comparison test across ﬁve biological replicates. Data represent the mean ± SEM.
The P-values for the Bonferroni multiple comparison tests are shown. *P ≤ 0.05; ***P ≤ 0.001. (D) p38 drives mTORC1 activity when PI3K is inactive. Quantiﬁcation of
data shown in Fig S14A. 4E-BP1-pT37/46 relative intensity was normalized separately for conditions without or with wortmannin. Signiﬁcance of 4E-BP1-pT37/46
inhibition by LY2228820 was tested using a two-tailed t test across ﬁve biological replicates. Data represent the mean ± SEM. *P ≤ 0.05. (E) Prediction on the extent of
mTORC1 inhibition upon LY2228820 treatment when PI3K is active or inactive. Prediction was performed with model V. The red lines depict the time points
measured experimentally (Fig 5A–C). (F) When PI3K activity declines, p38 drives mTORC1 activity. Quantiﬁcation of data shown in Fig S13L. MCF-7 cells were serum-starved
and treated with arsenite for 60 min in the presence of different concentrations of wortmannin (as indicated, PI3K inhibitor) in carrier (DMSO) versus LY2228820
(1 μM, p38 inhibitor)-treated cells. p70-S6K-pT389 relative intensity was normalized separately for each wortmannin concentration. Signiﬁcance of p70-S6K-pT389
inhibition by LY2228820 was tested using a two-tailed t test across ﬁve biological replicates. Data represent the mean ± SEM. *P ≤ 0.05. (G) p38 drives mTORC1 activity in
several cell lines, as PI3K activity declines. Quantiﬁcation of data shown in Fig S14D–G. MCF-7, CAL51, LN18, HEK293T, and HeLa cells were serum-starved and
exposed to arsenite for 60 min in combination with wortmannin (100 nM, PI3K inhibitor) and/or LY2228820 (1 mM, p38 inhibitor). Data represent 3–4 biological replicates
(see Fig S14D–G). 4E-BP1-pT37/46 relative intensity was normalized separately for conditions without or with wortmannin. Signiﬁcance of 4E-BP1-pT37/46 inhibition
by LY2228820 was tested using a two-tailed t test across three biological replicates. Data represent the mean ± SEM. *P ≤ 0.05; **P ≤ 0.01. (H) Stress granule
numbers upon PI3K and p38 inhibition. MCF-7 cells were serum-starved and treated with arsenite for 30 min in the presence of carrier (DMSO), wortmannin (100 nM, PI3K
inhibitor), LY2228820 (1 μM, p38 inhibitor), or wortmannin + LY2228820. Stress granules were visualized by immunoﬂuorescence staining of G3BP1. Nuclei were
visualized with Hoechst 33342. Data represent four biological replicates. White square indicates region of insert and blue arrow highlights stress granules; scale bar 10 μm.
(I) Quantiﬁcation of data shown in (H). The number of stress granules (SGs) per cell (normalized to the arsenite condition) across four biological replicates. Stress granule
formation between carrier and LY2228820 as well as wortmannin- and wortmannin + LY2228820–treated cells was compared using a two-tailed t test across four biological
replicates. Data represent the mean ± SEM. *P ≤ 0.01. ns, not signiﬁcant.
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Figure 6. PI3K, p38, and MK2 transduce stress signals to the mTOR network.
(A) Scheme summarizing the stress response of themTOR network. Three distinct cuesmediate stress signals to themTOR network. (1) Stress activates the RAS-PI3K-PDK1-
Akt axis, which in turn activates mTORC1. (2) The p38-MK2 axis signals to Akt-pS473. This stress input does not activate mTORC1. (3) p38 activates mTORC1, independently of
PI3K. Stress signaling tomTORC1 is required for stress granule assembly. The inhibitors used in this study are depicted. (B) p38 andmTORC1 activity speciﬁcally correlate in
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prominently, eIF2α kinases are considered as major stress granule
triggers (Anderson et al, 2015), as eIF2α kinases inhibit overall cap-
dependent translation by preventing the assembly of the ternary
complex (Holcik, 2015). In contrast to eIF2α kinases, the pro-stress-
granule-kinases PI3K and p38 identiﬁed here, as well as their
downstream target mTORC1, are perceived as translation en-
hancers (Gonskikh & Polacek, 2017; Robichaud & Sonenberg, 2017;
Saxton & Sabatini, 2017). So far, the oncogenic effects of PI3K, p38,
and mTORC1 have been mainly assigned to the fact that they
enhance metabolism, thereby promoting cell growth. Our results
suggest that through stress granule formation, PI3K, p38, and
mTORC1 also promote cell survival, adding to their oncogenic ca-
pacity. Hence, stress granule inhibition might be a valuable marker
to monitor the effectiveness of therapies targeting PI3K, p38, and
mTORC1. Of note, stress granule disruption by compounds has been
hitherto difﬁcult (Hu et al, 2017; Timalsina et al, 2018). The un-
derstanding of signaling cues mediating stress granule assembly
provides us new tools, such as PI3K and p38 inhibitors, to target
stress granules for research and therapies.
Also, the hierarchy of PI3K and p38 signaling to mTORC1 and
stress granules, established in the present study is of high
relevance for cancer treatment, as ongoing clinical trials com-
bine the p38 inhibitor LY2228820 with genotoxic therapies
(https://clinicaltrials.gov/ct2/show/NCT02364206 and https://
clinicaltrials.gov/ct2/show/NCT01663857), known to induce stress
granules (Moeller et al, 2004). Our ﬁndings suggest that this is a
promising strategy as LY2228820 inhibits stress induction of mTORC1
and stress granule formation, and this mechanism might be pre-
dominant in cancers with moderate or low PI3K activity. To in-
vestigate this in patient tissues, we analysed protein array data of the
invasive breast cancer dataset from The Cancer Genome Atlas (TCGA).
Indeed, we found in tumors with low PI3K activity that mTORC1
readouts (p70-S6K-pT389 and mTOR-pS2448) as well as Akt-S473
phosphorylation correlated with p38 activity (p38-pT180/Y182 [Corre
et al, 2017]) (Fig 6B). In contrast, when PI3K activity was high, phos-
phorylation of Akt-S473 and mTORC1 substrates did not correlate with
p38 phosphorylation. This suggests that p38 speciﬁcally activates Akt
and mTORC1 in tumors with low PI3K activity and that such patients
may exhibit a better response rate to p38 inhibitors. Thus, we advocate
cautious monitoring of PI3K readouts in clinical trials to predict
treatment outcome for p38 inhibitors.
Materials and Methods
Cell culture and cell treatments
Experiments were performed in MCF-7 cells overexpressing LC3-
GFP, a gift from Joern Dengjel. CAL51 (Cat. No. ACC 302) cells were
obtained from the Leibniz Institute DSMZ–German Collection of Cell
Cultures and Microorganisms. LN18 (Cat. No. CRL-2610) cells were
obtained from ATCC. HEK293T cells were obtained from the clinical
department of Freiburg University (Thien et al, 2015). HeLa, MCF-7,
and HEK293T cells were validated by DSMZ for their origin using
short tandem repeat analysis. The cells were cultured in DMEM (Cat.
No. P04-03600; PAN Biotech) supplemented with 10% FBS (Cat. No.
10270-106; Gibco) and 3 mM L-glutamine (Cat. No. 25030-024; Gibco)
at 37oC and 7.5% CO2. All cells were tested every three months for
mycoplasma contamination by performing a PCR on the cell su-
pernatant. 16 h before arsenite treatment (Cat. No. 3500-1L-R; Fluka
analytic), the cells were washed twice with PBS (Cat. No. P04–36500;
PAN) and afterwards cultivated in DMEM supplemented with 3 mM
L-glutamine at 37oC and 7.5% CO2 without FBS (serum starvation).
500 μM arsenite was added to the starvation medium for the in-
dicated durations. For inhibitor treatment, inhibitors were added
30 min before the arsenite treatment. Control cells were treated
with the corresponding carrier (DMSO) (Cat. No. D2650; Sigma-
Aldrich) at the same ﬁnal concentration.
siRNA knockdown was induced as follows: to induce IRS1 knock-
down, 5 nM siRNA single sequence were used for transfection and
incubated for 3 days (siIRS1 #1, target sequence UCAAAGAGGU-
CUGGCAAGU; siIRS1 #2 target sequence GAACCUGAUUGGUAUCUAC;
Dharmacon, Cat. No. LU-003015-00). ON-TARGETplus Human
SMARTpool (Dharmacon) was used to induce knockdown of the
following proteins: for Akt1 (Cat. No. L-003000-00) and Akt2 (Cat. No.
L-003001-00) knockdown, 10 nM siRNA was used for two days. To
knockdown rictor (Cat. No. L-016984-00), 20 nM siRNA was used for 4
days. To knockdown MK2 (Cat. No. L-003516-00), 20 nM siRNA was
used for 3 days. As a control, non-targeting scramble siRNA
(siControl, Cat. No. D-001810-10) was used at the same concen-
tration as the target siRNA. siRNA transfections were performed
using Lipofectamine 3000 (Cat. No. L3000008; Invitrogen) according
to the manufacturer’s protocol.
Antibodies and reagents
The following antibodies were purchased from Cell Signaling
Technology: p70-S6K-pT389 (Cat. No. 9206), p70-S6K (Cat. No. 9202),
PRAS40-pS183 (Cat. No. 5936), PRAS40-pT246 (Cat. No. 2997), PRAS40
(Cat. No. 2610), 4E-BP1-pT37/46 (Cat. No. 2855), 4E-BP1 (Cat. No. 9644),
Akt-pT308 (Cat. No. 4056), Akt-pS473 (Cat. No. 9271), Akt (Cat. No.
9272), Akt1 (Cat. No. 2938), Akt2 (Cat. No. 3063), TSC2-pT1462 (Cat. No.
3617), TSC2 (Cat. No. 4308), IRS1-pS636/639 (Cat. No. 2388), IRS1 (Cat.
No. 2382), eIF2α-pS51 (Cat. No. 9721), eIF2α (Cat. No. 9722), MK2-pT334
(Cat. No. 3007), MK2 (Cat. No. 3042), and RAF (Cat. No. 2662). GAPDH
antibody was bought from Abcam (Cat. No. ab8245), rictor antibody
from Bethyl Laboratories (Cat. No. A300-459A), and S6K-pT229 an-
tibody from GeneTex (Cat. No. GTX25231). Antibodies from Cell
Signaling Technology and GeneTex were used at a ﬁnal dilution of
1:1,000 in TBST (Tris-buffered saline-Tween) buffer (138 mM sodium
chloride, 2.7 mM potassium chloride, 66 mM Tris (pH 7.4), and 0.1%
breast cancer tissues with low PI3K activity. Analysis of RPPA from breast cancer patients obtained from TCPA. Patients were initially divided by the median of
Akt-T308 phosphorylation into two groups of (i) PI3K active and (ii) PI3K inactive. The PI3K active and PI3K inactive groups were further divided by the median of
the p38-pT180/Y182 phosphorylation into high p38 and low p38 activity groups. This separated the patients into four groups, namely, (1) PI3K active and p38 high,
(2) PI3K active and p38 low, (3) PI3K inactive and p38 high, and (4) PI3K inactive and p38 low. Data represent single measurements. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001;
****P ≤ 0.0001. ns, not signiﬁcant.
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Tween-20) with 5% BSA (Cat. No. 8076; Carl Roth). The anti-GAPDH
monoclonal antibody was used at a ﬁnal dilution of 1:10,000 in TBST
buffer with 5% BSA. All primary antibodies were used in 5% BSA in
TBST supplemented with 0.1% NaN3. Horseradish peroxidase-
conjugated goat anti-mouse (Cat. No. 31430) and goat anti-rabbit
IgG (Cat. No. 31460) were ordered from Thermo Scientiﬁc Pierce and
were used at a ﬁnal dilution of 1:8,000 in TBST buffer with 5% BSA.
For immunoﬂuorescence experiments, G3BP1 (Cat. No. sc-81940;
Santa Cruz) was used in a dilution of 1:200 as primary antibody in
0.3% FBS in PBS. Goat anti-mouse IgG Alexa Fluor 568 conjugate
(Cat. No. A-11031; Thermo Fisher Scientiﬁc) was used as secondary
antibody for immunoﬂuorescence experiments. For the RAS activity
assay, RAS (Cat. No. 05-516; Millipore) and RAF (Cat. No. 2662; Cell
Signaling Technology) antibodies were used at a dilution of 0.5 μg/
ml and 1:1,000 respectively. Secondary antibodies were purchased
from Li-Cor Bioscience and used at a ﬁnal dilution of 1:10,000: IRDye
680 Goat anti-Mouse IgG (Cat. No. 926-32220), IRDye 680 Goat anti-
Rabbit IgG (Cat. No. 926-32210), IRDye 800 Goat anti-Mouse IgG (Cat.
No. 926-32220), and IRDye 800 Goat anti-Rabbit IgG (Cat. No. 926-
32211).
The inhibitors used in this study were everolimus (Cat. No. S1120;
Selleck), wortmannin (Cat. No. 1232; Tocris), PF3644022 (Cat. No.
PZ0188-5MG; Sigma-Aldrich), Torin1 (Cat. No. 1833; Axon-Medchem),
AZD8055 (Cat. No. 1561; Axon Medchem), LY2228820 (Cat. No.
1895; Axon Medchem), GDC-0941 (Cat. No. 1377; Axon Medchem),
GSK2334470 (Cat. No. 4143/10; Tocris), and MK-2206 (Cat. No.
S1078; Selleckchem).
Cell lysis and immunoblotting
For lysis, the cells were washed twice with PBS and lysed with radio
immunoprecipitation assay buffer (1% IGEPAL CA-630, 0.1% SDS, and
0.5% sodium deoxycholate in PBS) supplemented with cOmplete
Protease Inhibitor Cocktail (Cat. No. 11836145001; Sigma-Aldrich),
Phosphatase Inhibitor Cocktail 2 (Cat. No. P5726; Sigma-Aldrich),
and Cocktail 3 (Cat. No. P0044; Sigma-Aldrich). Protein concentra-
tion was measured using Bio-Rad Protein Assay Dye Reagent
Concentrate (Cat. No. 500-0006; Bio-Rad) and adjusted to the lowest
value. Cell lysates were mixed with sample buffer (10% glycerol, 1%
β-mercaptoethanol, 1.7% SDS, 62.5 mM TRIS base (pH 6.8), and
bromophenol blue) and heated for 5 min at 95°C. Proteins were
then fractionated by size using SDS–PAGE. Acrylamide percentage
ranged from 8 to 14%, depending on the size of the proteins to be
detected. For separation, 90 to 180 V was applied and a Mini-
PROTEAN Tetra Vertical Electrophoresis Cell system (Cat. No.
1658029FC; Bio-Rad) with running buffer (0.2 M glycine, 25 mM Tris
base, and 0.1% SDS) was used. For protein membrane transfer, we
used polyvinylidene diﬂuoride membranes (Cat. No. IPVH00010;
Merck) and the PROTEAN Tetra Vertical Electrophoresis Cell system
with blotting buffer (0.1 M glycine, 50 mM TRIS base, 0.01% SDS (pH
8.3), and 10% methanol) at 45 V for 1 h and 50 min. The membranes
were blocked in 5% BSA in TBST. Primary antibodies were incubated
overnight at 4°C, and afterwards, the membranes were washed and
incubated for at least 2 h with the HRP-coupled secondary antibody
(goat–anti-mouse and goat–anti-rabbit). For detection, Pierce ECL
Western blotting substrate (Cat. No. 32209; Thermo Fisher Scientiﬁc)
or SuperSignal West FEMTO (Cat. No. 34095; Thermo Fisher
Scientiﬁc) was used to detect chemiluminescence using an LAS-
4000 mini camera system (GE Healthcare). Raw images taken with
the LAS-4000 mini system were exported as red green blue (RGB)
colour TIFF ﬁles using ImageJ and further processed with Adobe
Photoshop version CC2018. Quantiﬁcation of raw image ﬁles was
performed using ImageQuant TL version 8.1 (GE Healthcare).
Background subtraction was performed using the rolling ball
method, implemented in ImageQuant TL software, with a deﬁned
radius of 200 for all images. The pixel value of a given signal was
normalized to the average pixel intensity of all signals belonging
to the respective readout in a given experiment. Afterwards,
the signals were normalized to the loading control (GAPDH). The
GraphPad Prism 8 software was used for statistical analysis. The
number of biological replicates for each experiment is indicated in
the ﬁgure legends, and the single experimental values are depicted
as dots in the graphical representations. A one-way or two-way
ANOVA followed by a Bonferroni multiple comparison test or a two-
tailed t test was applied as indicated in the ﬁgure legends to
compare the signal intensities among different conditions across
the experiments.
Immunoﬂuorescence
For all immunoﬂuorescence experiments, the cells were washed
with PBS and ﬁxed with 4% paraformaldehyde (Cat. No.
1.04005.1000; Merck) in PBS for 5 min at room temperature. After
washing the cells three times with PBS, permeabilization was
performed with 0.1% Triton X-100 (Cat. No. 93443; Sigma-Aldrich) for
5 min at room temperature. The cells were washed in PBS and
blocked with 0.3% FBS in PBS for 30 min at room temperature.
Primary antibodies were diluted in 0.3% FBS in PBS and incubated
overnight at 4°C in a humid chamber. Next, the cells were washed
with PBS and incubated with secondary antibody (Alexa-568) and
Hoechst 33342 (end concentration 1 mg/ml; Cat. No. H3570; Invi-
trogen) diluted in 0.3% FBS in PBS for 30 min in a humid dark
chamber at room temperature. Slides (Cat. No. 4951PLUS4; Thermo
Fisher Scientiﬁc) were washed with PBS and water, and mounted
with Mowiol 4–88 solution (Cat. No. 07131; Carl Roth), which was
prepared according to the manufacturer’s instructions, including
sodium deoxycholate (Cat. No. D27802; Sigma-Aldrich) supple-
mented with 10% n-propyl-gallate (NPG; Cat. No. 8.205.990.100; VWR
International). The slides were analysed using ﬂuorescence mi-
croscopy. Z stack images (8 slides, 0.5 μm) were taken with an
AxioObserver Z1 compound microscope (Carl Zeiss) with an Apo-
tome (5 pictures per slide), 63× objective and an AxioCamMRm3 CCD
camera (Carl Zeiss). For quantitative analysis, maximum intensity
projections were generated from three to four representative ﬁelds
of view, which were captured for each condition with identical
exposure times and the same magniﬁcation. For presentation in
ﬁgures, maximum intensity projections were exported as TIFF with
no compression using Zen2012 blue edition software (Zeiss), and
brightness or contrast were adjusted for better visibility. Brightness
or contrast adjustment was not performed before quantiﬁcation,
and thus did not inﬂuence image quantiﬁcation. For quantiﬁcation
of stress granules, G3BP1-positive foci and number of cells were
manually counted over four representative ﬁelds of view for each
biological replicate. The relative number of stress granules per cell
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was calculated as the ratio between G3BP1-positive foci and
number of cells for each ﬁeld of view. The average of all repre-
sentative ﬁelds from each condition was normalized to the arsenite
condition, which was set to 1. Statistics were performed with
GraphPad Prism 8 by comparing the relative amounts of stress
granules per cell over all biological replicates between two con-
ditions using a two-tailed t test.
RAS assay
The RAS activity was studied on the basis of RAS–RAF interaction
using RBD agarose beads (Cat. No. 17-218; Millipore) according to the
manufacturer’s speciﬁcations. The cells were treated with arsenite
for the speciﬁed duration and were subsequently lysed in magne-
sium lysis buffer (25 mM Hepes (pH 7.5), 150 nM NaCL, 1% IGEPAL CA-
630, 10 mM MgCl2, and 1 mM EDTA) for 30 min on ice. Debris was
removed by centrifugation at 15,871 g for 15 min at 4°C, and cleared
lysates were subsequently used for protein measurement according
to the manufacturer’s instructions using Bradford reagent (Cat. No.
1856209; Pierce). Equal amounts of all protein lysates were sub-
sequently incubated with RBD agarose beads for 45 min at 4°C and
thereafter washed three times with magnesium lysis buffer by
centrifugation. Agarose beads were then resuspended in 40 μl of 2×
sample buffer, boiled for 5 min, and beads were collected by brief
centrifugation. 20 μl per sample were resolved on SDS–PAGE with
appropriate acrylamide percentage and transferred onto nitrocel-
lulose membranes (Cat. No. 10600002, Amersham; GE Healthcare Life
Sciences). The membranes were blocked with 5% non-fat dry milk in
TBST for 1 h at room temperature and thereafter incubated overnight
at 4°C with either anti-Ras or anti-GST primary antibodies diluted in
5% non-fat dry milk with TBST. A washing step with TBST followed,
and the membranes were subsequently probed with secondary
antibodies conjugated to either horseradish peroxidase (anti-rabbit/
mouse HRP-linked IgG antibody) or to a ﬂuorophore for 1 h at room
temperature. The membranes were washed again as described
above, and chemiluminescence was detected using GE Healthcare
ECL Western blotting detection reagents (Cat. No. RPM2106;
Ammersham ECL) and FluorChem M Scanner, whereas ﬂuorescence
was detected using the Li-Cor Odyssey Infrared System.
Mathematical model
The ﬁnal ordinary differential equation–based model including a
stress-related input on PI3K, on Akt-pS473, and on mTORC1 (model
V) comprises 25 species and 91 parameters. In general, the model
describes the activity state (e.g., phosphorylation) of the following
species: IR-β, IRS1, PI3K, PDK1, Akt, PRAS40, TSC2, p70-S6K, and 4E-BP1.
For the sake of simplicity, different compartments and cell volume
were neglected. All species activations and deactivations were
simulated using mass action kinetics. Inhibitions were simulated to
be concentration dependent, that is, the efﬁciency of inhibition
correlates with the concentration of the inhibiting species relative
to its total concentration (including active and inactive variants
based on phosphorylation states). If the concentration of the
inhibiting species variant (e.g., TSC2) equals that of the total
concentration of all species variants (e.g., TSC2 + TSC2_pT1462), then
that species variant is fully inhibiting its downstream target. A
Boolean-like inhibition scheme was applied for inhibitory inputs to
the model, for example, wortmannin or MK-2206, where only in the
presence of these components, their respective targets get fully
(PI3K) or partially (Akt) inhibited.
Parameter settings
Themodelwas parameterised on the following experimental datasets:
arsenite (Fig S1C), arsenite + wortmannin (Fig S3A), and arsenite +
MK-2206 (Fig S3C). The average relative intensities and standard de-
viations were determined for the following observable species:
Akt_pT308, Akt_pS473, TSC2_pT1462, PRAS40_pS183, PRAS40_pT246,
p70_S6K_pT389, p70_S6K_pT229, 4EBP1_T37/46, and IRS1_pS636
(Supplemental Data 7). In the case of Akt, PRAS40 and p70_S6K im-
munoblot data were linked to the total amount of phosphorylation of
the respective species (e.g., Akt_pS473 phosphorylation was linked to
the sum of Akt_pS473 and Akt_pT308_pS473). As at time point zero of
arsenite treatment the initial species concentrations vary across
datasets, we included condition-speciﬁc initial concentration pa-
rameters (arsenite, arsenite +wortmannin, and arsenite +MK-2206). To
keep the number of parameters as low as possible, we integrated
several assumptions: because mTORC1 and mTORC2 activities were
notmeasured directly, but rather through the phosphorylation of their
respective downstream targets, mTORC1 and mTORC2 were modelled
implicitly via their downstream effects (e.g., inhibition of mTORC1 by
TSC2 was realised by adding TSC2 inhibition to the phosphory-
lation of all mTORC1 readouts [Figs S2B, S5, S7, S9, and S11]). We used
PRAS40_pS183, p70_S6K_pT389, and 4EBP1_T37/46 as mTORC1 activity
readouts and Akt_pS473 as mTORC2 activity readout. Because MCF-7
cells were starved overnight against growth factors in all experiments,
activation via insulin was not included. The value for the inhibition
by MK-2206 and wortmannin was derived from the corresponding
readouts (Fig S2C–E). To reduce the number of model parameters
and as because of serum starvation, the mTOR network activity is
at baseline, we set the initial concentration of all double-
phosphorylated species (Akt_pT308_pS473, PRAS40_pT246_pS183,
and p70_S6K_pT229_pT389) to zero. Because the effectiveness of a
second phosphorylation for AGC kinases such as Akt and p70_S6K is
enhanced by its ﬁrst phosphorylation (Pearce et al, 2010), we applied a
factor of two to the second phosphorylation step relative to the
parameter responsible for the ﬁrst phosphorylation. The exact value
of the second step phosphorylation enhancement does not affect the
overall ﬁtting quality and the outcome of the predictions. We ﬁnally
assumed that dephosphorylation of the same phosphosite for the
species Akt, PRAS40, and p70_S6K is equal, regardless of the species’
current phosphorylation state (e.g., the parameter for the de-
phosphorylation of Akt_pS473 to Akt possesses the same value as
the parameter for the dephosphorylation of Akt_pT308_pS473 to
Akt_pT308). A summary of all simulated species, inputs, and param-
eters is provided as supplemental information (Figs S15 and S16 and
Tables S2 and S3).
Input search
The MATLAB toolbox data2dynamics (Raue et al, 2015), release
version 170117, was used for model setup, stress input search, and
parameter estimation. In addition to the available datasets that are
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presented in the data ﬁgures (Figs S1C, S3A, and C and Supple-
mental Data 7), artiﬁcial datasets without any stress input were
used. The additional data comprise constant values represented by
the initial values of the corresponding datasets (e.g., time point zero
values of the arsenite dataset [Fig S1C and D] were used for all
values of the artiﬁcial dataset without arsenite). This is necessary to
prevent artiﬁcial dynamic behaviour of the model. The feasible
range for parameter estimation of initial concentration parameters
was set to 10−5 and 101, except for Akt_pT308 under wortmannin
treatment, which was expressed as a fraction of the arsenite
dataset-speciﬁc initial concentration parameter, because of the
inhibitory effect of wortmannin on PI3K. The ﬁt quality of each
concurrent model version was assessed by scanning the solution
space with 500 repetitions of Latin hypercube sampling (LHS) and
gradient descent (Raue et al, 2013). The ﬁt quality was determined
by computing the Akaike information criteria (AIC). Also an AIC
version including a correction for small sample sizes (AICc) and the
Bayesian information criterion (BIC) were computed to assess and
compare ﬁt quality (Tables 1 and S1). Because of the semi-
quantitative nature of the immunoblot data, initial parameter
ranges for all parameters were set to 10-5 and 103 if not stated
otherwise (Figs S15 and S16 and Tables S2 and S3). All mass
action–related parameter ranges were set to 10−5 and 101, except for
parameters related to PI3K activation. The corresponding initial
parameter ranges were set to 10−5 and 10−2 to prevent an unrealistic
step-wise activation of the unobservable PI3K species upon stress.
The input search performed to ﬁnd the second stress input was
performed using the whole parameter space described above.
Parameter estimation and identiﬁability analysis
For the ﬁnal model (Fig S11 and Tables S2 and S3), an additional
parameter estimation was performed by an iterative approach of
proﬁle likelihood estimation (Raue et al, 2009) (PLE) and LHS500
(500 different starting points for LHS) runs, starting with the pa-
rameters associated with the initial concentration species, followed
by ﬁxing the remainder of free parameters. To narrow down the
solution space of free parameters, each subsequent parameter
identiﬁcation iteration was based on ﬁxed parameters of the last
rounds. Moreover, to reduce the parameter space for the model
with three stress inputs (model V), we created an artiﬁcial dataset
under the assumption that remaining levels of Akt-pS473, p70-S6K-
pT389, 4E-BP1-pT37/46, and PRAS40-pS183 after wortmannin in-
hibition are due to an additional input. The iterative process for
parameter estimation was initialized with an LHS500 run to ﬁnd
parameter values that best resembled our data. Next, a PLE run was
performed, resulting in a ﬁrst set of identiﬁable parameters that
were consequently ﬁxed. If PLE reported no identiﬁable parameter,
another LHS500 analysis was performed. The solutions of the
LHS500 run were analysed for the best portion of ﬁtting solutions by
analysing the goodness of ﬁt of all 500 solutions with k-means
clustering. Speciﬁcally, two clusters were sought and only solutions
corresponding to the cluster with the better mean χ2 ﬁtting value
were kept for further analysis (see Supplemental Data 8 for details).
The remaining parameter distributions were analysed per pa-
rameter for showing unimodal distributions, that is, ending nearly
always in the same value range regardless of the starting point for
parameter optimisation (Supplemental Data 1). Parameters with
unimodal value distributions were ﬁxed by identifying the maxi-
mum value of a nonparametric kernel-smoothing distribution over
each parameter-speciﬁc unimodal distribution. After this step,
another parameter iteration round was started with a new PLE
analysis until no remaining free parameters were left.
Text mining
To automatically mine publications that relate Akt or PDK2s with
other interactors, MEDLINE and the open access subset of PMC were
linguistically preprocessed. Required text analysis before actual
text mining (such as part of speech tagging) includes segmentation
of text into basic units (sentences and words), acronym recognition,
and shallow grammatical analysis, among others, and was con-
ducted by using tools from the JCore repository (Hahn et al, 2016).
Eligible texts for text mining included more than 28 million ab-
stracts from MEDLINE as of January 2018 and about 1.7 million full
texts from PMC (open access only) as of October 2017. Next, a
semantic analysis was carried out to identify the mention of genes
and interactions between them. Gene identiﬁcation and mapping
into the NCBI Gene database was performed using GeNo (Wermter
et al, 2009), whereas interactions were identiﬁed by using the tool
BioSem (Bui & Sloot, 2012). Next, the sentences in which BioSem
identiﬁed interactions were ﬁltered for the occurrence of the term
“stress” and scanned for references of Akt or PDK2s as interaction
member. Finally, results were manually curated to obtain the ﬁnal
result list of literature mentioning interaction events including Akt
or PDK2s (Supplemental Data 6).
TCGA data analysis
Harmonized HT-Seq counts of TCGA breast cancer patients were
downloaded from GDC (https://gdc.cancer.gov/) using TCGAbiolinks
(Colaprico et al, 2015), and only patients with the identiﬁer “primary
solid tumor” were retained. Level-4–normalized reverse phase
protein arrays (RPPA) of TCGA breast cancer patients were down-
loaded from The Cancer Proteome Atlas (TCPA) (http://tcpaportal.
org/tcpa). The patient dataset was reduced to the overlap between
both RPPA and RNA-seq datasets, and this dataset was used for all
further downstream analysis (n = 869). Patients were initially divided
by the median of Akt_pT308 phosphorylation into two groups of high
and low phosphorylation. In addition, the high or low Akt_pT308
group was further divided by the median of the p38_pT180Y182
phosphorylation into high and low groups. This grouped the patients
into four groups. Wilcoxon signed-rank test was applied for group
comparisons of Akt, Akt_pT308, Akt_pS473, p38MAPK, p38_pT180Y182,
p70-S6K, p70-S6K_pT389, mTOR, and mTOR_pS2448 measurements.
All analyses were run in R, version 3.4.4 (https://cran.r-project.org/),
with the Bioconductor version 3.6 (https://bioconductor.org/). All
graphical representations were generated using ggplot2, ggpubr, and
ggbeeswarm.
Data availability
The ﬁve models generated as a part of this study are provided as
Supplementary Data. Supplemental Data 1: Model without stress
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inputs. Supplemental Data 2: Model with a stress input on PI3K.
Supplemental Data 3: Model with a stress input on PI3K and Akt-
pS473. Supplemental Data 4: Model with a stress input on PI3K and
Akt-pS473, but Akt-pS473 alone cannot activate mTORC1. Supple-
mental Data 5: Model with a stress input on PI3K, Akt-pS473, and
mTORC1. The latter model is also deposited in the BioModels re-
pository (Chelliah et al, 2015) and assigned the accession number
MODEL1902140002.
All data on which the conclusions of this study are based are
available from the corresponding authors upon request.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201800257.
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